In utero exposure to maternal gestational diabetes mellitus (GDM) or hyperglycemia may increase risk of childhood adiposity in girls, according to a new study.
In utero exposure to maternal gestational diabetes mellitus (GDM) or hyperglycemia may increase risk of childhood adiposity in girls, according to a new study in Diabetes Care. The findings suggest a need for screening and intervention to slow intergenerational transmission of obesity.
In the longitudinal study, data from 421 mother-daughter pairs from Kaiser Permanente Northern California were evaluated. Maternal glucose levels were obtained from maternal medical records. Outcomes assessed included 3 different measures of the girls’ adiposity: ≥85th age-specific percentile for body mass index (BMI), percent body fat, and waist-to-height ratio.
After adjustment for maternal age at delivery, race/ethnicity, pregravid BMI, the age of the daughter, and the daughter’s age at puberty onset, having a mother who had GDM increased a girl’s risk of having a BMI ≥85th percentile or having percent body fat or waist-to-height in the highest quartile (Q4), when compared with those in the lowest quintile of blood glucose (odds ratio [OR] 3.56 [95% confidence interval {CI} 1.28–9.92]; OR 3.13 [95% CI 1.08–9.09]; and OR 2.80 [95% CI 1.00–7.84], respectively).
Legally speaking: Undignosed infection - or prematurity?
Significant interaction was found between GDM and pregravid BMI and girls whose mother had both risk factors had the highest odds of having a BMI ≥85th percentile (OR 5.56 [95%CI 1.70–18.2]; Q4 percent body fat, OR 6.04 [95%CI 1.76–20.7]; and Q4 waist-to-height ratio, OR 3.60 [95%CI 1.35–9.58]). A weaker association was found between hyperglycemia and the level of adiposity in offspring.
To get weekly advice for today's Ob/Gyn, subscribe to the Contemporary OB/GYN Special Delivery.
S4E1: New RNA platform can predict pregnancy complications
February 11th 2022In this episode of Pap Talk, Contemporary OB/GYN® sat down with Maneesh Jain, CEO of Mirvie, and Michal Elovitz, MD, chief medical advisor at Mirvie, a new RNA platform that is able to predict pregnancy complications by revealing the biology of each pregnancy. They discussed recently published data regarding the platform's ability to predict preeclampsia and preterm birth.
Listen
Prenatal SSRI or SNRI discontinuation not linked to adverse psychiatric outcomes
October 8th 2024In a recent study, similar rates of adverse psychiatric-related outcomes were reported among patients with discontinuation of selective serotonin reuptake inhibitors and serotonin-norepinephrine reuptake inhibitors vs those without discontinuation.
Read More